Pfizer Inc (PFE)
Financial leverage ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 213,396,000 | 219,476,000 | 216,193,000 | 221,095,000 | 226,501,000 | 215,021,000 | 220,168,000 | 195,617,000 | 197,206,000 | 195,349,000 | 195,290,000 | 183,841,000 | 181,477,000 | 179,188,000 | 169,920,000 | 158,818,000 | 154,229,000 | 178,983,000 | 177,934,000 | 166,336,000 |
| Total stockholders’ equity | US$ in thousands | 88,203,000 | 92,286,000 | 87,700,000 | 92,282,000 | 89,014,000 | 96,934,000 | 99,019,000 | 100,971,000 | 95,661,000 | 92,631,000 | 87,209,000 | 82,424,000 | 77,201,000 | 75,691,000 | 70,042,000 | 68,620,000 | 63,238,000 | 65,259,000 | 64,336,000 | 65,026,000 |
| Financial leverage ratio | 2.42 | 2.38 | 2.47 | 2.40 | 2.54 | 2.22 | 2.22 | 1.94 | 2.06 | 2.11 | 2.24 | 2.23 | 2.35 | 2.37 | 2.43 | 2.31 | 2.44 | 2.74 | 2.77 | 2.56 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $213,396,000K ÷ $88,203,000K
= 2.42
Pfizer Inc's financial leverage ratio has shown some fluctuations over the past few years, ranging from 1.94 to 2.77. The ratio indicates the extent to which the company relies on debt financing in relation to its equity. A higher ratio suggests a higher level of financial risk due to increased debt obligations, while a lower ratio reflects a more conservative capital structure.
Based on the data provided, we can observe that Pfizer's financial leverage ratio peaked at 2.77 in June 2020, indicating a higher reliance on debt at that point in time. Subsequently, the ratio decreased to 1.94 by March 2023, suggesting a reduction in debt relative to equity. However, the ratio increased again to 2.54 by December 2023 before stabilizing around 2.4 in the following quarters.
Overall, Pfizer's financial leverage ratio trend indicates a moderate level of debt in its capital structure, with some fluctuations observed over the years. It is essential for investors and stakeholders to closely monitor changes in the financial leverage ratio to assess the company's risk profile and financial stability.
Peer comparison
Dec 31, 2024